Conditions: Substance Withdrawal Syndrome
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 31
Healthy volunteers: no

Brief summary:
We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has shown anecdotal evidence of being affective for the treatment of withdrawal symptoms and we hope to determine whether this is affective.

Detailed description:

Arms:
arm 1: Placebo - sugar pill arm 2: Ondansetron

Interventions: intervention 1: Ondansetron and Placebo crossover
Intervention descriptions: intervention 1: None

Protocol document: